Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
09 December 2020 | Story UFS entral academic advising team | Photo Pixabay

It wasn’t easy, but we all got to this point because we stayed calm and made the effort to learn on even when it was difficult. 

The University of the Free State (UFS) has remained committed to supporting you in every way possible, and as you prepare for the final assessments, remember to access the support tools you will need in order to successfully complete the 2020 academic year: https://www.ufs.ac.za/toolsforsuccess 

Main exams are running from 30 November to 19 December 2020


All of the best, and break a pen in your upcoming final assessments. For those of you who will be graduating, we cannot wait to see you in that graduation attire; and those who still have some way to go, we cannot wait to serve you again in 2021 as we continue the pursuit of academic success!

Below are five main study tips that you can use for final assessment success:


1. Set a realistic study schedule
You might think that studying for eight hours straight for four days before the exam, will help you get through the work in time. See final edition of the #UFSLearnOn for more information.

2. Structure and organise your work

If your notes are organised, it is also easier for your brain to recall information, even when you become nervous during exams. 

3. Practise with an old exam/semester test paper
Practice makes perfect, and although the final assessments might look different in how they are administered, it will still help to practise using old tests and exams. 

4. Adapt your strategies to the content
What works for one module or even one learning outcome, might not be effective for another. You need to continually adapt your note-taking and study approaches. See #UFSLearnOn final edition for different study methods.

5. Healthy body, healthy mind
Your brain needs optimal care to perform at its best, and getting physically active (even if it is by jumping in one spot if space is limited) forces your body to release neurotransmitters responsible for positive emotions, which assist in retaining information in your memory … 
Download the final edition of #UFSLearnOn that points you towards the resources you’ll need to ace your final assessments and end 2020 off on a high note! 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept